19.11.2024 • NewsBarentzChemical Distribution

Unipex Solutions Becomes Barentz France

Dutch-based multinational distributor Barentz announced that Unipex Solutions France, which it acquired in 2022, transformed into Barentz France. This new structure marks a major strategic turning point, symbolizing the complete integration of Unipex within Barentz and strengthening its presence in France, the group said.

Barentz France will be headquartered in La Défense and will maintain and develop its activities at its French sites in Tours, Nanterre and Angers.

This move is expected to enable the new entity to benefit from the strength of a global group, while maintaining a strong local presence. By integrating Barentz's global resources and expertise, the new French team strengthens its ability to offer a wider range of sustainable ingredients and tailor-made solutions.

With expanded resources and better integration within a global network, Barentz France said that it is perfectly positioned to contribute even more effectively to its customers' success.

A complete rebranding in the Barentz colors will be launched shortly, the group said.

© Barentz
© Barentz

Company

Logo:

Barentz

Saturnusstraat 15
2132 HB Hoofddorp
Netherlands

Company contact







Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.